PKI-402

PKI-402

中文名称PKI-402
中文同义词1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲;PI3K/MTOR双重抑制剂(PKI-402)
英文名称PKI-402
英文同义词1-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(4-(1-methylpiperazine-4-carbonyl)phenyl)urea;1-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea;PKI-402;PKI402;1-(4-(3-Ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(4-(4-methylpiper;PKI-402;1-[4-[3-Ethyl-7-(morpholin-4-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl]phenyl]-3-[4-[(4-methylpiperazin-1-yl)carbonyl]phenyl]urea;CS-167;Urea, N-[4-[3-ethyl-7-(4-morpholinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]phenyl]-N'-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-
CAS号1173204-81-3
分子式C29H34N10O3
分子量570.65
EINECS号
相关类别信号转导通路激酶抑制剂;细胞生物学试剂;PI3K/Akt/mTOR;Akt;mTOR;PI3K
Mol文件1173204-81-3.mol
结构式PKI-402 结构式

PKI-402 性质

沸点670.6±55.0 °C(Predicted)
密度1.43
储存条件Store at -20°C
溶解度不溶于乙醇;不溶于水; DMSO 中≥14.28 mg/mL
形态固体
酸度系数(pKa)13.80±0.70(Predicted)

PKI-402 用途与合成方法

PKI-402是一种有效的,pan-PI3K/mTOR双重抑制剂,靶向作用于PI3Kα/β/γ/δ和mTOR,IC50分别为2 nM/7 nM/16 nM/14 nM和3 nM,也有效作用于PI3Kα突变型E545K和H1047R。Equivalent to the IC50 for wild-type PI3Kα, PKI-402 inhibits E545K and H1047R PI3Kα mutants with IC50 of 3 nM. In a panel of 236 human protein kinases, PKI-402 only displays inhibitory activity against C-Raf and B-Raf with IC50 of 7 μM, and displays little activity against all other kinases with IC50 of > 10 μM. PKI-402 inhibits the growth of human tumor cell lines with IC50 of 6-349 nM. Consistently, PKI-402 inhibits phosphorylation of PI3K and mTOR effector proteins, particularly phosphorylated Akt (p-Akt) at T308 and S473 with IC50 of <10 nM and <30 nM, respectively. PKI-402 inhibits both p70S6K and 4EBP1 phosphorylation with IC50 of <10 nM. PKI-402 inhibits Akt phosphorylation of PRAS40 at T246 with IC50 of <30 nM, and inhibits Akt phosphorylation of ENOS at S1177 and GSK3α/GSK3β at S9/S21 with IC50 of <10 nM. In MDAMB-361, a breast tumor line with mutant PI3K-α (E545K) and elevated levels of Her2 receptor, PKI-402 treatment induces cleaved poly(ADP-ribose) polymerase (PARP), a marker for apoptosis. Less than 10% of MDAMB-361 cells exposed to PKI-402 at 0.3 μM (or higher) for 24 hours remain viable.Single dose of PKI-402 (100 mg/kg) suppresses Akt phosphorylation (at T308) and induces cleaved PARP in MDA-MB-361 tumors. In normal tissue (heart and lung), PKI-402 (100 mg/kg) has minimal effect on p-Akt, with no detectable cleaved PARP. Consistently, PKI-402 at 100 mg/kg (daily for 5 days, one round) reduces initial tumor volume of 260 mm3 to 129 mm3 and prevents tumor regrowth for 70 days in MDA-MB-361. PKI-402 significantly inhibits the growth of A549 tumors in nude mice at 25 mg/kg and 50 mg/kg. PKI-402 at 100 mg/kg (daily for 5 days, one round) causes significant (P < 0.01) reduction in tumor growth of U87MG.

PI3Kα

2 nM (IC 50 )

PI3Kα-H1047R

3 nM (IC 50 )

PI3Kα-E545K

3 nM (IC 50 )

PI3Kβ

7 nM (IC 50 )

PI3Kδ

14 nM (IC 50 )

PI3Kγ

16 nM (IC 50 )

mTOR

3 nM (IC 50 )

安全信息

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2024/01/25HY-10683PKI-4021 mg613元
2024/01/25HY-10683PKI-402
PKI-402
1173204-81-35mg1350元

PKI-402 上下游产品信息

上游原料
"PKI-402"相关产品信息
依维莫司 硼替佐米 MK-22062HCl IPI-145 Apitolisib(GDC-0980,RG7422) NVP-BEZ235
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》